|

EBV TCR-T Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1

Indications

  • Peripheral T-cell Lymphoma (PTCL)1
  • NK/T-cell Lymphoma1
  • DLBCL1
  • Cancer1

Other1 trial

Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.